Avalo Therapeutics (AVTX) Scheduled to Post Quarterly Earnings on Wednesday

Avalo Therapeutics (NASDAQ:AVTX – Get Rating) will be issuing its quarterly earnings data on Wednesday, May 3rd. Avalo Therapeutics Price Performance AVTX traded down $0.08 during trading on Tuesday, hitting $3.00. The stock had a trading volume of 7,740 shares, compared to its average volume of 26,211. The company has a 50 day moving average […]

Related Keywords

,Avalo Therapeutics Company Profile ,Goldman Sachs Group Inc ,Millennium Management ,Renaissance Technologies ,Jefferies Financial Group ,Avalo Therapeutics Inc ,Caissa Capital Management Ltd ,Susquehanna International Group ,Avalo Therapeutics ,Get Rating ,Caissa Capital Management ,International Group ,Sachs Group ,Avalo Therapeutics Daily ,Nasdaq Avtx ,Avtx ,Medical ,Earnings ,